Membrane-Active Peptides and Their Potential Biomedical Application.
antimicrobial peptides
cancer
cell-penetrating peptides
membrane-active peptides
peptide synthesis
tumor-homing peptides
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
06 Aug 2023
06 Aug 2023
Historique:
received:
30
06
2023
revised:
24
07
2023
accepted:
03
08
2023
medline:
26
8
2023
pubmed:
26
8
2023
entrez:
26
8
2023
Statut:
epublish
Résumé
Membrane-active peptides (MAPs) possess unique properties that make them valuable tools for studying membrane structure and function and promising candidates for therapeutic applications. This review paper provides an overview of the fundamental aspects of MAPs, focusing on their membrane interaction mechanisms and potential applications. MAPs exhibit various structural features, including amphipathic structures and specific amino acid residues, enabling selective interaction with multiple membranes. Their mechanisms of action involve disrupting lipid bilayers through different pathways, depending on peptide properties and membrane composition. The therapeutic potential of MAPs is significant. They have demonstrated antimicrobial activity against bacteria and fungi, making them promising alternatives to conventional antibiotics. MAPs can selectively target cancer cells and induce apoptosis, opening new avenues in cancer therapeutics. Additionally, MAPs serve as drug delivery vectors, facilitating the transport of therapeutic cargoes across cell membranes. They represent a fascinating class of biomolecules with significant potential in basic research and clinical applications. Understanding their mechanisms of action and designing peptides with enhanced selectivity and efficacy will further expand their utility in diverse fields. Exploring MAPs holds promise for developing novel therapeutic strategies against infections, cancer, and drug delivery challenges.
Identifiants
pubmed: 37631305
pii: pharmaceutics15082091
doi: 10.3390/pharmaceutics15082091
pmc: PMC10459175
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Unitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii si Inovarii
ID : PN-III-P4-PCE-2021-0639
Références
J Clin Invest. 1990 Nov;86(5):1381-6
pubmed: 2243118
Microbiol Res. 2022 Jul;260:127039
pubmed: 35500455
Life (Basel). 2022 Sep 16;12(9):
pubmed: 36143476
Biochem Biophys Rep. 2022 Jul 01;31:101305
pubmed: 35812346
J Cereb Blood Flow Metab. 2015 Jun;35(6):993-1004
pubmed: 25669902
RSC Chem Biol. 2020 Dec 8;2(1):151-165
pubmed: 34458778
Food Chem. 2019 Jul 30;287:324-332
pubmed: 30857706
Biochim Biophys Acta Biomembr. 2021 Nov 1;1863(11):183697
pubmed: 34274319
Biochim Biophys Acta Biomembr. 2019 Oct 1;1861(10):182980
pubmed: 31067436
Am J Transl Res. 2019 Jul 15;11(7):3919-3931
pubmed: 31396309
Biophys J. 2023 Mar 21;122(6):1018-1032
pubmed: 36575795
ACS Nano. 2020 Oct 27;14(10):12370-12389
pubmed: 33001626
Front Pharmacol. 2015 Nov 10;6:272
pubmed: 26617524
Biochem Pharmacol. 2021 Nov;193:114769
pubmed: 34543656
Benef Microbes. 2023 Mar 14;14(1):57-72
pubmed: 36815495
Eur J Med Chem. 2023 Mar 5;249:115131
pubmed: 36669399
Eur J Med Chem. 2023 Mar 5;249:115147
pubmed: 36739750
Cell. 1988 Dec 23;55(6):1189-93
pubmed: 2849510
Biochim Biophys Acta Biomembr. 2023 Mar;1865(3):184118
pubmed: 36621762
Biophys Chem. 2023 May;296:106981
pubmed: 36871366
Micromachines (Basel). 2021 Nov 10;12(11):
pubmed: 34832789
Can J Infect Dis Med Microbiol. 2022 Feb 9;2022:6913772
pubmed: 35186175
Drug Discov Today. 2015 Jan;20(1):122-8
pubmed: 25450771
Nucleic Acids Res. 2023 Jan 6;51(D1):D1373-D1380
pubmed: 36305812
iScience. 2023 Feb 08;26(3):106157
pubmed: 36879819
Oncotarget. 2016 Sep 13;7(37):59322-59335
pubmed: 27528037
Sci Rep. 2022 Mar 7;12(1):4005
pubmed: 35256720
Molecules. 2022 Nov 03;27(21):
pubmed: 36364371
Plant Sci. 2022 Nov;324:111427
pubmed: 36007629
Biomolecules. 2018 Aug 22;8(3):
pubmed: 30135402
Biochemistry. 1982 Sep 28;21(20):5020-31
pubmed: 6814482
Pharmaceutics. 2018 Apr 30;10(2):
pubmed: 29710857
J Colloid Interface Sci. 2022 Mar;609:707-717
pubmed: 34839914
Database (Oxford). 2022 Mar 19;2022:
pubmed: 35305010
Biophys Chem. 2009 Sep;144(1-2):27-37
pubmed: 19560854
Cancers (Basel). 2021 Dec 22;14(1):
pubmed: 35008197
Antiviral Res. 2023 Apr;212:105575
pubmed: 36868316
Front Med Technol. 2020 Dec 11;2:610997
pubmed: 35047892
Biochim Biophys Acta Biomembr. 2022 Sep 1;1864(9):183978
pubmed: 35659865
Membranes (Basel). 2022 Feb 02;12(2):
pubmed: 35207101
J Biol Chem. 2014 May 23;289(21):14448-57
pubmed: 24706763
Clin Cancer Res. 2007 Aug 1;13(15 Pt 2):s4652-4
pubmed: 17671159
J Control Release. 2019 Sep 10;309:106-124
pubmed: 31323244
Signal Transduct Target Ther. 2022 Feb 14;7(1):48
pubmed: 35165272
Front Biosci. 2007 Jan 01;12:1833-44
pubmed: 17127424
Front Neurosci. 2017 Feb 14;11:73
pubmed: 28261050
Biochim Biophys Acta Biomembr. 2022 Oct 1;1864(10):183996
pubmed: 35753394
Peptides. 2021 Dec;146:170666
pubmed: 34600037
PLoS One. 2012;7(11):e50263
pubmed: 23226256
Genes (Basel). 2023 Apr 22;14(5):
pubmed: 37239313
Pharmaceuticals (Basel). 2022 Jun 08;15(6):
pubmed: 35745647
Eur J Biochem. 1971 May 11;20(1):89-102
pubmed: 5578618
Lab Chip. 2019 Feb 26;19(5):837-844
pubmed: 30698187
Int J Mol Sci. 2012;13(3):3229-3244
pubmed: 22489150
Biochim Biophys Acta Biomembr. 2022 Feb 1;1864(2):183820
pubmed: 34813768
Protein Cell. 2010 Feb;1(2):143-52
pubmed: 21203984
Biochim Biophys Acta Biomembr. 2017 Feb;1859(2):167-176
pubmed: 27836642
Neuropeptides. 2023 Jun 23;101:102356
pubmed: 37390744
Trends Pharmacol Sci. 2012 Apr;33(4):186-92
pubmed: 22424670
Pharmaceutics. 2020 Mar 03;12(3):
pubmed: 32138146
Anal Chem. 2022 Jul 12;94(27):9530-9539
pubmed: 35760038
Biochimie. 2013 Jan;95(1):12-9
pubmed: 22824150
Physiol Res. 2018 Oct 30;67(Suppl 2):S267-S279
pubmed: 30379549
Arch Med Res. 2021 Jan;52(1):15-24
pubmed: 32950264
Front Chem. 2018 Jun 05;6:204
pubmed: 29922648
Mol Biotechnol. 2023 Sep;65(9):1387-1402
pubmed: 36719639
Vaccines (Basel). 2021 Nov 04;9(11):
pubmed: 34835209
Pharmaceuticals (Basel). 2014 May 13;7(5):545-94
pubmed: 24828484
Biochim Biophys Acta. 2007 Jul;1768(7):1796-804
pubmed: 17531950
Mater Sci Eng C Mater Biol Appl. 2020 May;110:110712
pubmed: 32204024
Hemasphere. 2022 Feb 25;6(3):e687
pubmed: 35243210
Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1864-8
pubmed: 1672046
Comput Struct Biotechnol J. 2022 Nov 12;20:6192-6205
pubmed: 36420150
Prog Biophys Mol Biol. 2023 Mar;178:32-49
pubmed: 36801471
Biochim Biophys Acta Biomembr. 2023 Jan 1;1865(1):184080
pubmed: 36328080
Sci Rep. 2021 Apr 7;11(1):7628
pubmed: 33828175
J Immunol Res. 2015;2015:761820
pubmed: 26568964
Mar Drugs. 2022 Aug 02;20(8):
pubmed: 36005504
Bioorg Chem. 2023 Jan;130:106252
pubmed: 36379149
Nat Rev Drug Discov. 2011 Dec 16;11(1):37-51
pubmed: 22173434
J Immunother Cancer. 2022 Feb;10(2):
pubmed: 35193933
Biochemistry. 1992 Dec 22;31(50):12688-94
pubmed: 1472506
Mol Biol Rep. 2022 Oct;49(10):10039-10050
pubmed: 35606604
PLoS One. 2015 Oct 14;10(10):e0139652
pubmed: 26465925
Sci Rep. 2013;3:1607
pubmed: 23558316
Biochim Biophys Acta Biomembr. 2022 Feb 1;1864(1):183806
pubmed: 34656552
Drug Discov Today. 2012 Aug;17(15-16):850-60
pubmed: 22465171
Protein Sci. 2013 Jul;22(7):870-82
pubmed: 23649542
Biophys J. 2023 Mar 21;122(6):1058-1067
pubmed: 36680343
Pharmaceutics. 2021 Jun 15;13(6):
pubmed: 34204007
Acta Biomater. 2023 Feb;157:210-224
pubmed: 36503077
Acc Chem Res. 2016 Jun 21;49(6):1130-8
pubmed: 27187572
Nanomaterials (Basel). 2021 Apr 26;11(5):
pubmed: 33925983
Arch Biochem Biophys. 2021 Mar 15;699:108751
pubmed: 33421380
Appl Microbiol Biotechnol. 2014 Jul;98(13):5807-22
pubmed: 24811407
Comput Struct Biotechnol J. 2023 Mar 02;21:1995-2008
pubmed: 36950221
Amino Acids. 2017 Jun;49(6):1053-1067
pubmed: 28314993
Database (Oxford). 2012 Mar 07;2012:bas015
pubmed: 22403286
Colloids Surf B Biointerfaces. 2022 May;213:112384
pubmed: 35151994
Pharmaceuticals (Basel). 2013 Nov 28;6(12):1543-75
pubmed: 24287494
Arch Pharm Res. 2012 Mar;35(3):409-13
pubmed: 22477186
Drug Discov Today. 2023 Feb;28(2):103464
pubmed: 36481586
Respir Res. 2022 Oct 10;23(1):276
pubmed: 36217139
Antibiotics (Basel). 2020 Jan 13;9(1):
pubmed: 31941022
Cancer Sci. 2021 Jun;112(6):2118-2125
pubmed: 33793015
J Cancer Res Clin Oncol. 2020 Jun;146(6):1533-1543
pubmed: 32281025
J Appl Microbiol. 2022 Mar;132(3):1573-1596
pubmed: 34606679
Biochim Biophys Acta Gen Subj. 2022 Nov;1866(11):130218
pubmed: 35905923
Int J Mol Sci. 2023 Mar 17;24(6):
pubmed: 36982826
FASEB J. 1998 Jan;12(1):67-77
pubmed: 9438412
Molecules. 2022 Oct 25;27(21):
pubmed: 36364057
Oncol Lett. 2021 Jul;22(1):501
pubmed: 33981363
Front Pharmacol. 2020 May 20;11:697
pubmed: 32508641
FEMS Microbiol Rev. 2021 Jan 8;45(1):
pubmed: 32876664
Pharmaceutics. 2023 Feb 20;15(2):
pubmed: 36840033
Foods. 2022 Aug 11;11(16):
pubmed: 36010415
J Oncol. 2019 Jun 26;2019:9367845
pubmed: 31346334
Front Cell Infect Microbiol. 2021 Jun 14;11:668632
pubmed: 34195099
Membranes (Basel). 2021 Jan 20;11(2):
pubmed: 33498372
Nat Rev Drug Discov. 2006 Jul;5(7):585-95
pubmed: 16816839
Chem Rev. 2020 Mar 25;120(6):3210-3229
pubmed: 31804810
Probiotics Antimicrob Proteins. 2021 Dec;13(6):1521-1529
pubmed: 34282568
Beilstein J Nanotechnol. 2020 Jan 9;11:101-123
pubmed: 31976201
Front Microbiol. 2022 Sep 21;13:965621
pubmed: 36212827
Peptides. 2023 Jan;159:170900
pubmed: 36336169
FEBS Lett. 2003 Jan 30;535(1-3):23-8
pubmed: 12560072
Eur J Pharm Sci. 2022 Aug 1;175:106205
pubmed: 35561952
Biomed Pharmacother. 2018 Dec;108:1090-1096
pubmed: 30372809
Fish Shellfish Immunol. 2022 Jul;126:357-369
pubmed: 35661768
Acta Pharm Sin B. 2023 Feb;13(2):498-516
pubmed: 36873165
Eng Life Sci. 2018 Apr 14;18(8):532-550
pubmed: 32624934
Antibiotics (Basel). 2020 Sep 19;9(9):
pubmed: 32961656
Vaccines (Basel). 2021 Jan 14;9(1):
pubmed: 33466608
Molecules. 2017 Nov 08;22(11):
pubmed: 29117144
J Biol Chem. 2023 Apr;299(4):103056
pubmed: 36822328